Pharmacogenomics

Home / Special Interest Groups / Pharmacogenomics

The Pharmacogenomics SIG addresses molecular mechanisms, clinical impact and public health implications of genomics affecting drug response and adverse effects.
Chair: Andrew Somogyi (andrew.somogyi@adelaide.edu.au)

Link to forum (opens in a new tab): https://groups.google.com/a/asceptsigs.org/forum/#!forum/pharmacogenomics
Access to SIG forums is a member only benefit.